GLOBAL AT HOME TESTING KITS MARKET: OVERVIEW
As per Roots Analysis, the global at home testing kits market is estimated to grow from USD 14.8 billion in the current year to USD 31.15 billion by 2035, at a CAGR of 6% during the forecast period, till 2035.
The market sizing and opportunity analysis has been segmented across the following parameters:
Type of Test Format
- Strip
- Stick
- Cassette
- Others
Type of Biofluid Analyzed
Therapeutic Area
- Fertility and Reproductive Health
- Metabolic Disorders
- Infectious Diseases
- Oncological Disorders
Area of Application
- Diagnostics
- Research
- Therapeutics
- Other Areas of Applications
Key Geographical Regions
- North America (US, Canada and Rest of North America)
- Europe (UK, Germany, France, Italy, Spain and Rest of Europe)
- Asia Pacific (India, China, Japan, South Korea, Indonesia and Rest of Asia-Pacific)
- Africa (Nigeria, Ethiopia, Egypt and Rest of Africa)
- South America (Argentina, Brazil and Rest of South America)
GLOBAL AT HOME TESTING KITS MARKET: GROWTH AND TRENDS
In the healthcare industry, digitization has evolved over time with numerous advancements, ensuring equitable access to novel health products and medical devices. Self- testing kits can improve health equity and accelerate progress towards universal health coverage, and it has the ability to improve health care. Self-testing kits provide individuals and communities with simple, quick, and private means to diagnose and treat a wide range of diseases, including HIV, hepatitis C, COVID-19, and, most recently, syphilis. People can now direct their own illness screening and make decisions based on their results safely, effectively, securely, and conveniently owing to more accessible and affordable self-tests and the expanding self-care movement.

Owing to several advantages offered by at-home self-testing kits for diagnostics and screening purposes, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such kits to provide healthcare at a fraction of a cost to the general public when compared to traditional clinics. Associated cost saving and privacy are main drivers of the growth of this domain over the coming decade. Currently, more than 650 at-home self-testing kits are available worldwide and are approved by regulatory authorities. The market is highly fragmented, featuring the presence of both new entrants and established players, based in different geographical regions.
GLOBAL AT HOME TESTING KITS MARKET: KEY INSIGHTS
The report delves into the current state of global at home testing kits market and identifies potential growth opportunities within industry. Some key findings from the report include:
- Over 510 at-home self-test kits have been developed for the screening, monitoring and diagnosis of a myriad of diseases, including diabetes, colon cancer and HIV.
- Majority of the at-home self-testing strips are primarily being used for monitoring diabetes and have received approval from regulatory authorities, such as the USFDA, ISO and IVD.

- Presently, more than 51% of the total at-home self-testing kit developers are based in North America.
- It is worth noting that most of the at-home self-testing kits are currently being used for monitoring disorders (43%), followed by those employed for detection of conditions related to fertility and reproductive health (22%).
- Most of the kits are being developed to follow invasive route for the procurement of analyte (56%), followed by those being manufactured to utilize non-invasive methods for procuring analyte (43%).
- More than 1,130 academic grants have been awarded to industry players to support the ongoing efforts related to research and innovation of at-home self-testing kits, over the past few years.
- Several non-profit organizations have extended financial support to aid the research related to at-home self-testing kits. It is worth mentioning that NIAID emerged as the most prominent non-profit organization, having awarded over 23% of grants for a period of 1-5 years, followed by NHLBI (12%).
- In order to gain competitive edge, firms continue to improve and benchmark their existing capabilities and capacities to offer a number of at-home self-testing solutions.
- Cost is a key determinant of the acceptance and adoption of assay kits; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their offerings.
- Due to competitive pricing of products and rapid innovation being led by companies in this market, there are various lucrative opportunities for long term investments, with high possibility of positive return on investments.
- The current capacity is adequate to satisfy global annual demand; however, we expect that industry players will continue to invest in additional capacity to address long-term growth and rising future demand.
- It is worth highlighting that the demand for HIV screening kits is expected to grow at a rate of 13%. Further, the highest demand for such products is expected to be generated by the Asia-Pacific region in 2035 (56%).
- In the long-term, the overall projected opportunity is likely to be segregated across various therapeutic areas, biofluids analyzed, test formats and key geographical regions.

- The current market is driven by kits developed for metabolic disorders (64%); this trend is unlikely to change in the foreseen future as well. Further, based on type of test format, strip-based tests are likely to have the maximum revenue generation potential (50%), by 2035.
Example Players in the At Home Testing Kits Market
- ACON Laboratories,
- AdvaCare Pharma USA
- Apex Biotechnology
- i-SENS
- Oak Tree Health
- TaiDoc Technology
- VivaCheck Laboratories
GLOBAL At Home Testing Kits Market: RESEARCH COVERAGE
- Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global antiviral drugs market, focusing on key market segments, including [A] type of test format, [B] type of biofluid analyzed, [C] therapeutic area, [D] area of application and [E] key geographical regions.
- Market Landscape: A comprehensive evaluation of companies engaged in the development of at-home self-testing kits, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of testing procedure, [E] type of test format, [F] purpose of testing, [G] target therapeutic area, [H] wearability, [I] analyte procurement method, [J] biofluid analyzed, [K] processing time, [L] kit components, [M] regulatory approvals / certifications, [N] kit reusability, [O] availability of data management tools, [P] target analyte detected and [P] follow-up consultation requirement.
- Grant Analysis: An in-depth analysis of academic grants that have been awarded to various research institutes for conducting research focused on at-home self-testing kits, based on various relevant parameters, such as [A] year of grant award, [B] amount awarded, [C] support period, [D] type of funding institute center, [E] grant application, [F] purpose of grant award, [G] grant activity code, [H] NIH spending category, [I] study section involved, [J] popular NIH departments, [K] recipient organization, [L] regional distribution of recipient organization.
- Company Competitiveness Analysis: A comprehensive competitive analysis of at-home self-testing kit manufacturers, examining factors, such as [A] overall experience of the company, [B] product portfolio strength and [C] portfolio diversity.
- Company Profiles: In-depth profiles of companies engaged in offering at-home self-testing kits, focusing on [A] company overviews, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
- Bowman Clock Pricing Strategy: A comprehensive assessment to understand the pricing strategy of the at home self-testing kits offered by a firm, along with its competitive position in the market.
- Company Comparable Analysis: An in-depth analysis of company's intrinsic value by using comparable company analysis of publicly listed companies based on various parameters, such as [A] their current share price, [B] equity value, [C] enterprise value, [D] EBITDA, [E] net income and [F] revenue.
- Demand Analysis: A comprehensive analysis of annual demand for at-home self-testing kits, across various therapeutic areas, such as [A]] fertility and reproductive health, [B] metabolic disorders, [C] infectious diseases and [D] oncological disorders.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How many companies are currently engaged in this market?
- Which are the leading companies in this market?
- What factors are likely to influence the evolution of this market?
- What is the current and future market size?
- What is the CAGR of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
REASONS TO BUY THIS REPORT
- The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
- Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
- The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
ADDITIONAL BENEFITS
- Complimentary PPT Insights Packs
- Complimentary Excel Data Packs for all Analytical Modules in the Report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with Research Team
- Free Updated report if the report is 6-12 months old or older